TY - JOUR
T1 - Perillaldehyde inhibits AHR signaling and activates NRF2 antioxidant pathway in human keratinocytes
AU - Fuyuno, Yoko
AU - Uchi, Hiroshi
AU - Yasumatsu, Mao
AU - Morino-Koga, Saori
AU - Tanaka, Yuka
AU - Mitoma, Chikage
AU - Furue, Masutaka
N1 - Publisher Copyright:
Copyright © 2018 Yoko Fuyuno et al.
PY - 2018
Y1 - 2018
N2 - The skin covers the outer surface of the body, so the epidermal keratinocytes within it are susceptible to reactive oxygen species (ROS) generated by environmental pollutants such as benzo(a)pyrene (BaP), a potent activator of aryl hydrocarbon receptor (AHR). Antioxidant activity is generally mediated by the nuclear factor-erythroid 2-related factor-2 (NRF2) and heme oxygenase-1 (HO1) axis in human keratinocytes. Perillaldehyde is the main component of Perilla frutescens, which is a medicinal antioxidant herb traditionally consumed in East Asia. However, the effect of perillaldehyde on the AHR/ROS and/or NRF2/HO1 pathways remains unknown. In human keratinocytes, we found that perillaldehyde (1) inhibited BaP-induced AHR activation and ROS production, (2) inhibited BaP/AHR-mediated release of the CCL2 chemokine, and (3) activated the NRF2/HO1 antioxidant pathway. Perillaldehyde is thus potentially useful for managing inflammatory skin diseases or disorders related to oxidative stress.
AB - The skin covers the outer surface of the body, so the epidermal keratinocytes within it are susceptible to reactive oxygen species (ROS) generated by environmental pollutants such as benzo(a)pyrene (BaP), a potent activator of aryl hydrocarbon receptor (AHR). Antioxidant activity is generally mediated by the nuclear factor-erythroid 2-related factor-2 (NRF2) and heme oxygenase-1 (HO1) axis in human keratinocytes. Perillaldehyde is the main component of Perilla frutescens, which is a medicinal antioxidant herb traditionally consumed in East Asia. However, the effect of perillaldehyde on the AHR/ROS and/or NRF2/HO1 pathways remains unknown. In human keratinocytes, we found that perillaldehyde (1) inhibited BaP-induced AHR activation and ROS production, (2) inhibited BaP/AHR-mediated release of the CCL2 chemokine, and (3) activated the NRF2/HO1 antioxidant pathway. Perillaldehyde is thus potentially useful for managing inflammatory skin diseases or disorders related to oxidative stress.
UR - http://www.scopus.com/inward/record.url?scp=85056594228&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056594228&partnerID=8YFLogxK
U2 - 10.1155/2018/9524657
DO - 10.1155/2018/9524657
M3 - Article
C2 - 29951165
AN - SCOPUS:85056594228
SN - 1942-0900
VL - 2018
JO - Oxidative medicine and cellular longevity
JF - Oxidative medicine and cellular longevity
M1 - 9524657
ER -